Ameriprise Financial Inc Madrigal Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,511 shares of MDGL stock, worth $329,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,511

Previous 1,613 6.32%

Holding current value

$329,080

Previous $430,000 1.63%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$193.33 - $291.99 $19,719 - $29,782	-102 Reduced 6.32%	1,511 $423,000
Q1 2024 May 15, 2024	SELL	$171.37 - $283.23 $593,968 - $981,675	-3,466 Reduced 68.24%	1,613 $430,000
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $1,926 - $3,794	16 Added 0.32%	5,079 $1.18 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $241,550 - $373,440	-1,654 Reduced 24.62%	5,063 $739,000
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $1.1 Million - $1.69 Million	5,406 Added 412.36%	6,717 $1.55 Million
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $27,727 - $36,849	-120 Reduced 8.39%	1,311 $317,000
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $83,556 - $424,348	1,431 New	1,431 $415,000
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $653,380 - $914,986	-9,787 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $101,894 - $143,266	-1,209 Reduced 10.99%	9,787 $892,000
Q3 2019 Nov 14, 2019	BUY	$84.4 - $106.53 $384,864 - $485,776	4,560 Added 70.85%	10,996 $948,000
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $73,359 - $114,712	-805 Reduced 11.12%	6,436 $675,000
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $8,795 - $12,226	85 Added 1.19%	7,241 $907,000
Q4 2018 Feb 14, 2019	BUY	$94.77 - $215.54 $258,722 - $588,424	2,730 Added 61.68%	7,156 $807,000
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $684,504 - $991,623	-3,302 Reduced 42.73%	4,426 $948,000
Q2 2018 Aug 14, 2018	SELL	$101.55 - $313.9 $119,524 - $369,460	-1,177 Reduced 13.22%	7,728 $2.16 Million
Q1 2018 May 15, 2018	SELL	$93.35 - $149.04 $1.06 Million - $1.69 Million	-11,363 Reduced 56.06%	8,905 $1.04 Million
Q4 2017 Feb 12, 2018	BUY	$39.35 - $97.37 $797,545 - $1.97 Million	20,268	20,268 $1.86 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

21.9M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.72B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Madrigal Pharmaceuticals, Inc. Transaction History